Kinetic Medical(SZ:300326) Sou Hu Cai Jing·2025-05-13 01:58Core Viewpoint - Kelly Tai has appointed Wang Chong as the new chairman of the board, marking the third chairman change within two months, indicating instability in the company's leadership [1][3]. Group 1: Leadership Changes - Wang Chong was elected as the chairman with a vote of 4 in favor, 0 against, and 2 abstentions [1]. - The abstentions were due to concerns about the company's governance structure and the lack of sufficient board members, as the current board has not yet reached the required number of seven [2]. - Wang Chong has an extensive background in biomedical engineering and management, having held various positions in medical technology and investment firms [2]. Group 2: Company Background - Kelly Tai is a high-end medical device group established in 2005, focusing on providing clinical treatment solutions for patients with osteoporosis-related vertebral compression fractures [3]. - The company became the first orthopedic medical device company to be listed on the A-share market in China in June 2012 [3]. Group 3: Financial Performance - In 2024, Kelly Tai reported a revenue of 985 million yuan, a year-on-year increase of 2.96%, but incurred a net loss of 106 million yuan compared to a profit of 113 million yuan in the previous year [4]. - For the first quarter of 2024, the company achieved a revenue of 265 million yuan, reflecting a year-on-year growth of 7.56%, and a net profit of approximately 21.76 million yuan, which is a significant increase of 100.03% [4]. Group 4: Stock Status - Kelly Tai's stock has been placed under special risk warning since May 6, 2025, with its trading name changed from "Kelly Tai" to "ST Kelly," while the stock code remains the same [3]. - The company is facing audit challenges, as the auditing firm was unable to obtain sufficient evidence regarding the completeness of disclosures related to equity investments and related party transactions [4].